News | February 02, 2015

Volpara Signs Agreement With GE Healthcare to Distribute Products to Help Improve Dense Breast Cancer Screening

Products to Help Improve Dense Breast Cancer Screening Volumetric breast density and quantitative breast imaging solutions to support screening and supplemental breast imaging modalities

Mammography systems, women's health, RSNA 2015, Volpara, GE Healthcare

Image courtesy of Volpara

February 2, 2015 — To help improve breast cancer screening for the 40 percent of American women with dense breasts, Volpara Solutions announced it has signed an agreement enabling GE Healthcare to distribute VolparaDensity, VolparaAnalytics and VolparaDoseRT.

Under the agreement, GE Healthcare customers will have the option to purchase from GE Healthcare Volpara Solutions’ innovative suite of quantitative breast imaging tools that enable personalized measurements of volumetric density, patient-specific dose, breast compression and other factors designed to provide critical insight for breast imaging quality and workflow.

To date, more than 4 million women have had their breast density analyzed, using VolparaDensity, which is in use at breast imaging centers worldwide to help radiologists objectively assess density from both digital mammography and tomosynthesis images and to help determine which women with dense breasts may benefit from additional screening, such as with the GE Invenia Automated Breast Ultrasound (ABUS).

VolparaAnalytics is a dashboard that produces configurable reports for management of quality assurance, resource utilization and breast imaging workflow. VolparaDose provides a standardized measurement of patient-specific dose with consistent dose results across mammography systems from different manufacturers.

GE Healthcare’s breast care solution is designed to address the needs of each unique woman: 3D breast tomosynthesis, automated breast ultrasound (ABUS), contrast-enhanced spectral mammography (CESM), molecular breast imaging (MBI), breast magnetic resonance imaging (MRI) and healthcare IT workflows.

“We know that screening using our automated breast ultrasound has a 37% relative increase in cancer detection overall than mammography alone in women with dense breasts,” said Jessie Jacob, M.D., MMM, chief medical officer of Breast Health at GE Healthcare.  

For more information: www.volparasolutions.com, www.gehealthcare.com

                                                

Related Content

GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium

GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium in Hollywood, Florida. Photo by Greg Freiherr

Feature | Breast Imaging | April 23, 2019 | By Greg Freiherr
Signs of what the future may look like in women’s health dotted the exhibit floor of the...
In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr
Commercial efforts to develop...
Videos | Breast Imaging | April 18, 2019
In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...
Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer. Permission to publish provided by DenseBreast-info.org

Feature | Breast Imaging | April 18, 2019 | By Greg Freiherr
When planning a screening program to detect the early signs of breast cancer, age is a major consideration.
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
compressed breast during mammography.
360 Photos | 360 View Photos | April 16, 2019
A 360 view of a simulated breast compression for a...
A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images

A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images. The algorithm, described at the SBI/ACR Breast Imaging Symposium, used “Deep Learning,“ a form of machine learning, which is a type of artificial intelligence. Graphic courtesy of Sarah Eskreis-Winkler, M.D.

Feature | Artificial Intelligence | April 12, 2019 | By Greg Freiherr
The use of smart algorithms has the potential to make healthcare more efficient.
This image depicts ABUS images with QVCAD results

This image depicts ABUS images with QVCAD results.

Feature | Breast Imaging | April 12, 2019
Imaging Technology News spoke with Bob Foley, vice president of sales and marketing of QView Medical, Inc.,